RCIM
ONC

Russell Clark Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Russell Clark Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-45,200
Closed -$7.59M – 69
2018
Q1 		$7.59M Sell
45,200
-1,000
-2% -$135K 1.51% 23
2017
Q4 		$4.51M Buy
+46,200
New +$4.23M 0.95% 30

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Russell Clark Investment Management's ONC Position: Q2 2018 in Review

Russell Clark Investment Management sold out of BeOne Medicines Ltd (ONC) in Q2 2018, closing a stake of 45,200 shares — an estimated $7.59M sold.

Russell Clark Investment Management first reported a position in ONC in Q4 2017 and held it in 2 quarters. The position peaked at $7.59M in Q1 2018. 128 funds tracked by Wall St. Rank hold ONC as of Q2 2018.

  • Russell Clark Investment Management reported no remaining BeOne Medicines Ltd position as of Q2 2018 after selling out during the quarter.
  • Russell Clark Investment Management sold 45,200 BeOne Medicines Ltd shares in Q2 2018, an estimated $7.59M.
  • Russell Clark Investment Management first reported a position in BeOne Medicines Ltd in Q4 2017 and held it in 2 quarters.
  • Russell Clark Investment Management's BeOne Medicines Ltd position peaked at $7.59M in Q1 2018.
  • 128 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2018.

Based on Russell Clark Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.